Next Science shifts sales strategy as Q3 revenue dips 7%
Next Science Limited (ASX:NXS), a Sydney-based medical technology company, has reported a 7% dip in product sales for the third quarter of FY24, generating US$4.7 million. The decline follows the restructuring of its Durable Medical Equipment (DME) sales channel. Despite these challenges, the company remains optimistic about future growth, with total year-to-date sales up 5%. […]
Next Science shifts sales strategy as Q3 revenue dips 7% Read More »